全文获取类型
收费全文 | 15000篇 |
免费 | 740篇 |
国内免费 | 153篇 |
专业分类
耳鼻咽喉 | 190篇 |
儿科学 | 307篇 |
妇产科学 | 188篇 |
基础医学 | 2263篇 |
口腔科学 | 359篇 |
临床医学 | 1359篇 |
内科学 | 2823篇 |
皮肤病学 | 537篇 |
神经病学 | 1154篇 |
特种医学 | 802篇 |
外科学 | 2098篇 |
综合类 | 74篇 |
一般理论 | 2篇 |
预防医学 | 676篇 |
眼科学 | 387篇 |
药学 | 1345篇 |
中国医学 | 188篇 |
肿瘤学 | 1141篇 |
出版年
2023年 | 101篇 |
2022年 | 320篇 |
2021年 | 512篇 |
2020年 | 280篇 |
2019年 | 361篇 |
2018年 | 406篇 |
2017年 | 344篇 |
2016年 | 491篇 |
2015年 | 657篇 |
2014年 | 762篇 |
2013年 | 831篇 |
2012年 | 1314篇 |
2011年 | 1195篇 |
2010年 | 747篇 |
2009年 | 667篇 |
2008年 | 857篇 |
2007年 | 890篇 |
2006年 | 767篇 |
2005年 | 697篇 |
2004年 | 566篇 |
2003年 | 455篇 |
2002年 | 430篇 |
2001年 | 325篇 |
2000年 | 297篇 |
1999年 | 235篇 |
1998年 | 98篇 |
1997年 | 94篇 |
1996年 | 59篇 |
1995年 | 66篇 |
1994年 | 36篇 |
1993年 | 33篇 |
1992年 | 89篇 |
1991年 | 70篇 |
1990年 | 89篇 |
1989年 | 82篇 |
1988年 | 82篇 |
1987年 | 55篇 |
1986年 | 58篇 |
1985年 | 49篇 |
1984年 | 31篇 |
1983年 | 35篇 |
1981年 | 29篇 |
1980年 | 19篇 |
1979年 | 39篇 |
1978年 | 45篇 |
1977年 | 28篇 |
1976年 | 21篇 |
1975年 | 33篇 |
1974年 | 27篇 |
1973年 | 20篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
71.
Prof. T. E. Oh S. Bhatt E. S. Lin R. C. Hutchinson J. M. Low 《Intensive care medicine》1991,17(4):199-203
Previous studies on oxygen consumption (
) during weaning from mechanical ventilation assumed that an increase in
(
) reflected oxygen consumption by respiratory muscles (
), and proposed
as a weaning predictor. We measured
CO2 production (
) and plasma catecholamines in 20 short-term ventilated patients during weaning by SIMV and CPAP.
as a percentage of
during spontaneous ventilation (
%) ranged from 4.8% to 41.5%.
also increased and correlated with
. Plasma adrenaline and noradrenaline increased significantly to levels known to produce considerable increases in metabolic rate. Mean arterial pressure and heart rate concomitantly increased, but spontaneous minute ventilation decreased. Thus, since the increased plasma catecholamines are calorigenic, the assumption that
represents
is incorrect. Although mean
% of successfully weaned patients was significantly less than that of failure-to-wean patients, the wide scatter of individual values in the latter group excludes
% as an accurate weaning predictor. 相似文献
72.
Selective neuronal survival and upregulation of PCNA in the rat inner retina following transient ischemia 总被引:1,自引:0,他引:1
Ju WK Kim KY Hofmann HD Kim IB Lee MY Oh SJ Chun MH 《Journal of neuropathology and experimental neurology》2000,59(3):241-250
In this study we investigated the extent and time course of neuronal cell death and the regulation of the proliferating cell nuclear antigen (PCNA) in the different retinal cell layers following ischemia-reperfusion injury. Retinal ischemia was induced by controlled elevation of the intraocular pressure for a duration of 60 min. Changes in thickness and cell numbers in the retinal cell layers were analyzed at various time points (1 h to 4 weeks) after reperfusion. In parallel, apoptotic cell death was determined by the TUNEL method and the expression of PCNA analyzed by immunocytochemistry. In addition, we tested whether PCNA is expressed in neurons by double immunocytochemistry. The reduction in thickness was found to be less pronounced in the inner nuclear layer (INL). Correspondingly, cell numbers decreased by only 33% in the inner retina, but by more than 80% in the outer nuclear layer (ONL). Alterations in glial cell numbers did not contribute significantly to postischemic changes in the INL and ONL as assessed by using immunocytochemical markers for microglial and Müller cells. The time course of cell death determined by the TUNEL technique also differed markedly in the retinal layers being rapid and transient in the inner retina but delayed and prolonged in the ONL. PCNA immunoreactivity was undetectable in the normal retina, but was specifically induced in neurons of the inner retina within 1 h after reperfusion and was sustained for at least 4 weeks. We conclude that in contrast to photoreceptors in the ONL, a significant proportion of inner retinal neurons is resistant to ischemic insult induced by transiently increased intraocular pressure and that PCNA may possibly play a role in the selective postischemic survival of these cells. 相似文献
73.
It has been suggested that transient osteoporosis or the bone marrow oedema syndrome (BMOS) may be the initial phase of osteonecrosis of the femoral head (ONFH) and that there may be a common pathophysiology. In this study, we have assessed the MR images of 200 consecutive patients with ONFH in respect of the BMO pattern in order to test this hypothesis. This pattern was not observed in the early stage of ONFH. The initial abnormal finding detected on the MR images was an abnormal band of intensity at the junction between the necrotic area and the normal bone. Structural damage of the head seems to result in the appearance of the BMO pattern and the development of pain in ONFH. There was no finding to support the existence of a continuum between BMOS and ONFH. 相似文献
74.
Salicylate enhances necrosis and apoptosis mediated by the mitochondrial permeability transition. 总被引:1,自引:0,他引:1
Onset of the mitochondrial permeability transition (MPT) causes both necrotic and apoptotic cell death in cultured hepatocytes. Salicylate lowers the threshold for onset of the MPT. In this study, our aim was to determine whether nontoxic concentrations of salicylate potentiate MPT-mediated cell killing. In necrotic killing models to rat hepatocytes, salicylate (1 mM) enhanced calcium ionophore (Br-A23187)- and tert-butylhydroperoxide (t-BuOOH)-induced cell death, which was blocked or delayed by cyclosporin A (CsA, 2 microM), a specific inhibitor of the MPT. In hepatocyte apoptosis induced by tumor necrosis factor-alpha (TNF-alpha), salicylate accelerated cell killing after low-dose TNF-alpha (1 ng/ml), which by itself induced little apoptosis. Salicylate enhancement of apoptosis was associated with onset of the MPT and accelerated caspase 3 activation. Salicylate also augmented killing of MCF-7 human breast tumor cells by etoposide and PLC/PRF/5 human hepatoma cells by tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). In conclusion, salicylate potentiates both necrotic and apoptotic cell killing by promoting onset of the MPT. Enhancement by salicylate of MPT-dependent apoptosis may play a role in protection by aspirin and other nonsteroidal anti-inflammatory drugs against colon, lung, and breast cancer. 相似文献
75.
Dural repair using acellular human dermis: experience with 200 cases: technique assessment 总被引:47,自引:0,他引:47
Warren WL Medary MB Dureza CD Bellotte JB Flannagan PP Oh MY Fukushima T 《Neurosurgery》2000,46(6):1391-1396
OBJECTIVE: Many craniotomies require a watertight dural closure. When primary dural repair is not possible, a graft is necessary. Autograft material is not always easily accessible or available, necessitating the use of other material. We performed 200 craniotomies using an acellular human dermal graft (AlloDerm; LifeCell Corp., The Woodlands, TX) to determine its suitability as a dural substitute. METHODS: From June 1996 through March 1998, all patients at Allegheny General Hospital who required a dural substitute graft and in whom autograft harvest was impractical or impossible received the acellular dermal autograft. The running suture technique was used to form a watertight seal. RESULTS: After follow-up for a minimum of 1 year, seven patients have required subsequent surgery. Three patients developed cerebrospinal fluid leaks that were repaired without removing the dermal graft. Four patients developed wound infections that required debridement. In each patient, the graft seemed to be uninvolved in the infectious process and was left in place. The patients were administered antibiotics postoperatively, and there have been no recurrent infections. No adhesion formation or scarring was noted around or underneath the graft in any patient. CONCLUSION: AlloDerm is a reasonable alternative to the available dural graft materials. Its handling characteristics are similar to those of dura, it is biologically inert, and it does not produce adhesion formation. 相似文献
76.
Glenn Liu David R Gandara Primo N Lara Derek Raghavan James H Doroshow Przemyslaw Twardowski Philip Kantoff William Oh KyungMann Kim George Wilding 《Clinical cancer research》2004,10(3):924-928
PURPOSE: Flavopiridol is a cyclin-dependent kinase inhibitor with preclinical activity against prostate cancer cell lines. A Phase II trial was conducted to determine the activity of flavopiridol in patients with metastatic hormone-refractory prostate cancer. EXPERIMENTAL DESIGN: A total of 36 patients was enrolled from several institutions and treated with a 72-h continuous infusion of flavopiridol every 14 days at the eventual starting dose of 40 mg/m(2)/day. Dose escalation up to 60 mg/m(2)/day was permitted if no significant toxicity was observed. Responses were assessed every 12 weeks. Only those patients completing four courses of the 72-h infusion were considered evaluable for response because the primary objective was to determine progression-free survival at 6 months given the cytostatic nature of the agent. RESULTS: This study was conducted in a two-stage fashion. During the first stage, at least 20 evaluable patients needed to be enrolled to assess response. There were 22 of 36 patients evaluable for response. No objective responses were observed. Only 4 patients had stable disease for 16, 26, 29, and 48 weeks, respectively, stopping the trial by design as only 3 of 22 (14%) of the patients met the 6-month progression-free survival end point. The most common toxicities were diarrhea (grade 1 and 2) and nausea, although some grade 3 and 4 diarrhea (11 and 6%, respectively) were evident. CONCLUSIONS: Flavopiridol has disappointing single-agent activity in hormone-refractory prostate cancer when administered at this dose and schedule. Its use in prostate cancer should be reserved for evaluation in combination therapies or alternative schedules. 相似文献
77.
78.
79.
80.
Oh BR Sasaki M Perinchery G Ryu SB Park YI Carroll P Dahiya R 《The Journal of urology》2000,163(5):1584-1587
PURPOSE: Tumor necrosis factor-alpha (TNF-alpha) is involved in oncogenesis of several cancers. The purpose of this study was to investigate whether genotype changes of TNF-alpha promoter regions (-238, -308) and at the 488 region are associated with human prostate cancer. MATERIALS AND METHODS: The DNA from 73 cases of human prostate cancer was analyzed by allele-specific polymerase chain reaction to characterize the genotype changes of three regions of the TNF-alpha gene in prostate cancer patients. We also determined the genotype frequency in these patients. The relative risk of variant genotype was calculated by comparing with our previous data from healthy controls. RESULTS: Genetic changes were detected in 15.1% (11/73) of prostate cancer samples at 488 region of TNF-alpha. Seventy-three percent (53/73) of the patients showed genotype GA at -308 region of TNF-alpha. Genotype GA at 488 region in TNF-alpha was observed in 73% (53/73) of the cancer and 71% (52/73) of the normal tissue. The relative risks of incidence for prostate cancer was 14-fold higher in people with genotype GA at -308 region of TNF-alpha. The relative incidence for prostate cancer was a 17-fold higher in-patient with genotype GA at 488 region of TNF-alpha. Genotype GA at -308 of TNF-alpha was related to higher clinical tumor stage of prostate cancer than genotype G (p <0.05). CONCLUSIONS: The present study demonstrates, for the first time, that the genotype changes in -308 and 488 regions of TNF-alpha are associated with prostate cancer. 相似文献